I do enjoy research and that includes reviewing old press releases from PTSC. Back in 2006 PTSC issued a PR about an unprecendented move to issue a dividend. This was on the heels of a PR about Lincoln/Swartz owning 20million warrants and being issued 7 million more warrants as consideration for certain agreements. Was the dividend really further consideration for certain agreements while throwing shareholders a bone?

· …. Lincoln and Swartz will immediately convert their remaining convertible debentures of the Company, following which the Company will not have any debt on its balance sheet.

· To facilitate the conversion of the debentures, agreements between the Company and Lincoln and Swartz which prohibit each of Lincoln and Swartz from owning more than 4.99% of the Company's Common Stock will be amended to allow them to own up to 9.99% of the Common Stock. With their holdings exceeding 5% they will need to make appropriate SEC filings upon future dispositions of the Company's stock.

· The Company will have the right to redeem up to 20 million warrants owned by Lincoln and Swartz.

· The exercise prices of Company warrants held by Lincoln and Swartz will no longer be subject to downward resets based on the trading price of the Company's Common Stock.

· The Company will issue 7,000,000 warrants to Lincoln and Swartz in consideration for the agreements.

· The agreements were negotiated directly with Lincoln Ventures, LLC, and Swartz Private Equity, according to Patriot Scientific Chairman and CEO David Pohl. "These agreements are an important step toward freeing the Company from the burden of certain debt and equity financing transactions that enabled the Company to remain viable in previous years," Pohl stated. "During the past 12 months the Company has undergone significant changes in management and operating strategy and is now in a favorable cash position as a result of licensing revenues related to our patent portfolio that is jointly owned with the TPL Group. We are pleased that the principals of the Swartz and Lincoln organizations were willing to provide financing in the past and that they are now demonstrating their confidence in the future of Patriot Scientific by entering into these new agreements

Patriot Scientific will issue a cash dividend of $0.02 per share of common stock for shareholders and qualified warrant holders of record as of February 24, 2006.